Posters & Publications :: Cellectar Biosciences, Inc. (CLRB)

Efficacy of repeated injections of CLR 131 (I-131-CLR1404) in a MES SA/Dx5 athymic nude mouse model. (ASCO 2017 abstract)

Apr 25, 2017

Oliver K Kandela I

Iopofosine I 131

CLR1404, a Tumor-selective Alkyl Phosphocholine Analog, Increases Radiation Sensitivity in Solid Tumors [poster presentation]

Apr 25, 2016

Elsaid, M.Y. Otto, Mario

CLR1404

Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood−Brain Barrier Model

Apr 25, 2016

Clark, Paul Shusta, Eric

PLEs

Therapeutic combination of radiolabeled CLR140 with external beam radiation in head and neck cancer model systems

Apr 25, 2015

Morris, Zachary Harari, Paul

CLR1404

Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma

Apr 25, 2015

Marino, Roberta Otto, Mario

CLR1404

A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies

Apr 25, 2015

Lubner, Sam Liu, Glenn

Iopofosine I 131